Several other brokerages have also recently commented on CTEC. Deutsche Bank AG reiterated a buy rating and issued a GBX 330 ($4.35) price target on shares of ConvaTec Group PLC in a research note on Monday, July 31st. Numis Securities Ltd reiterated a reduce rating and issued a GBX 260 ($3.43) price target on shares of ConvaTec Group PLC in a research note on Thursday, August 3rd. Goldman Sachs Group, Inc. (The) reiterated a buy rating and issued a GBX 340 ($4.49) price target on shares of ConvaTec Group PLC in a research note on Thursday, August 3rd. J P Morgan Chase & Co decreased their target price on shares of ConvaTec Group PLC from GBX 318 ($4.20) to GBX 303 ($4.00) and set an overweight rating on the stock in a research report on Friday, August 4th. Finally, Citigroup Inc restated a neutral rating and set a GBX 290 ($3.83) target price on shares of ConvaTec Group PLC in a research report on Wednesday, October 11th. One analyst has rated the stock with a sell rating, six have given a hold rating and four have assigned a buy rating to the stock. ConvaTec Group PLC presently has an average rating of Hold and an average price target of GBX 266.70 ($3.52).
Shares of ConvaTec Group PLC (LON CTEC) opened at GBX 182 ($2.40) on Tuesday.
In other news, insider Frank Schulkes acquired 50,000 shares of ConvaTec Group PLC stock in a transaction that occurred on Tuesday, October 31st. The shares were bought at an average cost of GBX 196 ($2.59) per share, with a total value of £98,000 ($129,321.72). Also, insider Christopher Gent acquired 38,889 shares of ConvaTec Group PLC stock in a transaction that occurred on Wednesday, October 18th. The stock was purchased at an average cost of GBX 213 ($2.81) per share, for a total transaction of £82,833.57 ($109,307.96).
ConvaTec Group PLC Company Profile
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with our FREE daily email newsletter.